SCHEMBL9369115

SCHEMBL9369115

CC(Sc1nccn1Cc1cccs1)N(C)C

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HSP90AA1 P07900 1/20 0.37
▸ HSP90B1 P14625 1/20 0.37
▸ OPRK1 P41145 5/20 0.36
▸ TSHR P16473 3/20 0.34
▸ ALDH1A1 P00352 3/20 0.34
▸ CYP1A2 P05177 3/20 0.34
▸ CYP2D6 P10635 3/20 0.34
▸ CYP2C9 P11712 2/20 0.34
▸ HPGD P15428 2/20 0.34
▸ CYP3A4 P08684 2/20 0.34
▸ CASP1 P29466 2/20 0.34
▸ HSD17B10 Q99714 2/20 0.34
▸ CYP2C19 P33261 1/20 0.34
▸ CASP7 P55210 1/20 0.34
▸ SMN1; SMN2 Q16637 2/20 0.33
▸ HTT P42858 2/20 0.33
▸ CHRM2 P08172 1/20 0.33
▸ CHRM5 P08912 1/20 0.33
▸ ADRA2A P08913 1/20 0.33
▸ CHRM1 P11229 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9368527 0.81 — —
SCHEMBL10691914 0.80 HSP90AA1 (0.41) HSP90AA1HSP90B1OPRK1TSHRALDH1A1
SCHEMBL10775310 0.80 HSP90AA1 (0.35) HSP90AA1HSP90B1TSHRCYP1A2CYP2D6
SCHEMBL9369097 0.78 RAB9A (0.49) HSP90AA1HSP90B1LMNATP53KMT2A
SCHEMBL9369119 0.78 HTR7 (0.43) HSP90AA1HSP90B1OPRK1ALDH1A1CYP1A2
SCHEMBL9369816 0.78 HSP90AA1 (0.37) HSP90AA1HSP90B1ALDH1A1CYP1A2CYP2D6
SCHEMBL9369394 0.76 MEN1 (0.32) ALDH1A1CYP1A2CYP2D6CYP2C9CYP3A4
SCHEMBL9371807 0.75 FGFR1 (0.35) —
SCHEMBL9368824 0.73 — —
SCHEMBL9368544 0.72 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0244803-B1 Novel dopamine beta hydroxylase inhibitors MERRELL DOW PHARMA (US) 1994-10-26 — — EP disclosed
EP-0244803-A2 Novel dopamine beta hydroxylase inhibitors MERRELL DOW PHARMACEUTICALS INC. (US) 1987-11-11 — — EP disclosed
Send feedback